Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility and Effects of Mindfulness Based Relapse Prevention (MBRP) on Reducing Craving and Addictive Behaviour in Adults With Substance Abuse Disorders

NCT04034732 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04034732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04034732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility and Effects of Mindfulness Based Relapse Prevention (MBRP) on Reducing Craving and Addictive Behaviour in Adults With Substance Abuse Disorders
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2019
Completion date
August 31, 2024
Enrollment
80 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

substance abuse, substance use disorders